Stay updated on Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes appears above the study-record error page, and the displayed site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:50:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T22:07:02.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a Home button, indicating that access to the study record is restricted. This replaces the previous study details view with an error screen.
    Difference
    0.5%
    Check dated 2026-09-29T22:08:37.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The study detail page now displays a 403 Forbidden error instead of the study record content. A Home button is present on the error screen.
    Difference
    19%
    Check dated 2026-09-22T23:34:35.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a newer build of the page. This reflects an underlying update to the page framework rather than new study data.
    Difference
    0.1%
    Check dated 2026-09-15T22:52:11.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.6.5 to v3.6.6, marking a new version of the study page.
    Difference
    0.1%
    Check dated 2026-09-01T19:37:17.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Adrenocortical Carcinoma Clinical Trial page.